Inferensys

Glossary

De Novo Protein Design

The computational creation of entirely new protein sequences and structures that do not exist in nature, designed to perform a specific function.
Stylish WeWork-like workspace with hot desks and document wall, professional searching through enterprise knowledge base on a mounted ultrawide display, warm industrial pendants overhead.
COMPUTATIONAL BIOLOGY

What is De Novo Protein Design?

De novo protein design is the computational creation of entirely new protein sequences and three-dimensional structures that do not exist in nature, engineered to perform a specific biological function.

De novo protein design is the rational, computation-driven engineering of novel proteins from first principles, rather than modifying existing natural templates. Unlike directed evolution or template-based modeling, this approach solves the inverse folding problem—designing an amino acid sequence predicted to fold into a target backbone structure—to create molecules with tailored catalytic, binding, or structural properties that have never been sampled by evolution.

Modern pipelines integrate diffusion models, ProteinMPNN, and physics-based force fields like Rosetta to jointly optimize sequence and structure. Validation relies on metrics such as AlphaFold2's pLDDT and Predicted Aligned Error (PAE) to confirm the design folds as intended, followed by experimental characterization via cryo-EM or X-ray crystallography.

COMPUTATIONAL PROTEIN ENGINEERING

Key Characteristics of De Novo Protein Design

De novo protein design moves beyond modifying existing scaffolds to computationally construct entirely novel proteins from first principles. These systems integrate physics-based energy functions with deep generative models to create sequences and structures that do not exist in nature, targeting specific binding, catalytic, or structural functions.

01

Backbone Generation

The foundational step of constructing a novel 3D protein scaffold without a natural template. Modern methods use diffusion models and SE(3)-equivariant neural networks to generate physically plausible backbone geometries. Key approaches include:

  • Frame-based diffusion: Iteratively denoises residue frames (translation and rotation) to produce valid backbones
  • Constrained hallucination: Optimizes random sequences against structure prediction networks to yield novel folds
  • Fragment assembly: Combines short peptide fragments from the PDB into new topologies The generated backbone must satisfy Ramachandran plot constraints and avoid steric clashes before sequence design proceeds.
~10^300
Theoretical Sequence Space
< 1 Å
State-of-the-Art Backbone Accuracy
02

Inverse Folding & Sequence Design

The computational task of designing an amino acid sequence predicted to fold into a specified target backbone. Tools like ProteinMPNN use message-passing neural networks to predict optimal residue identities given local and global structural context.

  • Rotamer libraries: Discrete side-chain conformations are sampled to pack the hydrophobic core
  • Energy scoring: Rosetta energy functions or learned potentials evaluate sequence-structure compatibility
  • Diversity constraints: Sequences are optimized for solubility and to avoid aggregation-prone motifs This step effectively solves the inverse protein folding problem, generating sequences that stabilize the designed backbone.
52%+
Experimental Success Rate (ProteinMPNN)
~200ms
Per-Residue Design Speed
03

Function-First Design

Proteins are designed to perform a specific biochemical function from scratch. This requires precise geometric specification of active sites, binding pockets, or catalytic residues before backbone generation.

  • Binding site scaffolding: Matching a target ligand's geometry with complementary side-chain placement
  • Theozyme construction: Placing catalytic residues in optimal geometries to stabilize transition states
  • Parametric design: Using coiled-coil or repeat protein parameters to build modular functional scaffolds
  • De novo enzymes: Creating active sites with non-natural catalytic mechanisms not found in biology Functional validation requires experimental characterization of binding affinity (KD) or catalytic efficiency (kcat/KM).
pM-nM
Achievable Binding Affinity
10^6-fold
Catalytic Rate Enhancement
04

Hallucination & Unconstrained Generation

A technique where a structure prediction network like AlphaFold2 or RoseTTAFold is used in reverse to generate novel proteins. By optimizing a random input sequence to produce a confident predicted structure, the network 'hallucinates' new folds.

  • Loss optimization: Maximizing pLDDT and minimizing PAE drives the network toward novel, well-folded structures
  • Diversity sampling: Different random seeds produce structurally diverse outputs
  • Inpainting: Specifying fixed functional motifs while hallucinating the surrounding scaffold This method leverages the implicit knowledge of folding landscapes learned by prediction models without requiring explicit energy functions.
100s
Novel Structures per Run
> 90
Mean pLDDT of Hallucinated Designs
05

Experimental Validation & Iteration

Computational designs must be experimentally validated and refined. The design-build-test cycle integrates wet-lab characterization with computational feedback.

  • Recombinant expression: Designs are synthesized as genes, expressed in E. coli or cell-free systems
  • Biophysical characterization: Circular dichroism confirms secondary structure; SEC-MALS verifies monodispersity
  • High-resolution structure determination: X-ray crystallography or cryo-EM confirms atomic-level accuracy
  • Deep mutational scanning: High-throughput functional assays provide fitness landscapes for iterative redesign Failed designs inform improved energy functions and sampling strategies, closing the loop between computation and experiment.
< 1 Å
Cα RMSD to Design Model
2-4 weeks
Typical Design-Test Cycle
06

Conditional & Topological Design

Advanced methods that impose specific geometric or topological constraints during generation. These approaches enable the creation of proteins with predetermined shapes and symmetries.

  • Symmetry-constrained design: Generating cyclic, dihedral, or icosahedral protein assemblies
  • Topological specification: Designing proteins with predetermined knot types or chain entanglement patterns
  • Parametric backbone curves: Defining the overall protein shape using mathematical splines before sequence design
  • Pore and channel design: Creating transmembrane barrels with specified conductance properties These techniques are critical for designing protein nanomaterials, vaccine nanoparticles, and synthetic membrane proteins.
120-subunit
Largest Designed Icosahedron
Å-precision
Pore Diameter Control
DE NOVO PROTEIN DESIGN

Frequently Asked Questions

Clear, technically precise answers to the most common questions about the computational creation of entirely new proteins from first principles.

De novo protein design is the computational creation of entirely new protein sequences and 3D structures that do not exist in nature, engineered from physicochemical first principles to perform a specific function. Unlike directed evolution, which iteratively mutates an existing natural protein scaffold and selects for improved variants in the laboratory, de novo design builds a protein from scratch. The process typically begins by defining a target backbone geometry that can stabilize a desired active site or binding interface, then uses inverse folding algorithms like ProteinMPNN to generate an amino acid sequence predicted to fold into that blueprint. This approach allows engineers to access completely novel folds and functions beyond the constraints of natural evolutionary history, enabling the creation of protein logic gates, self-assembling nanomaterials, and custom biocatalysts with no natural homologs.

PROTEIN STRUCTURE DETERMINATION PARADIGMS

De Novo Design vs. Template-Based Modeling vs. Ab Initio Prediction

A comparison of three distinct computational strategies for determining or creating protein three-dimensional structures, distinguished by their dependence on experimental data and physical principles.

FeatureDe Novo DesignTemplate-Based ModelingAb Initio Prediction

Primary Objective

Create novel, non-natural sequences that fold into a specified structure

Model a target sequence's structure using a known homologous structure

Predict a target sequence's structure from physicochemical principles alone

Dependence on Experimental Data

None required for design; validated post hoc

High; requires a solved homologous template

None; relies solely on physics-based energy functions

Input

Target backbone structure (backbone generation) or functional constraints

Target amino acid sequence and a template structure from the PDB

Target amino acid sequence only

Core Algorithmic Approach

Inverse folding (e.g., ProteinMPNN), hallucination, or diffusion models

Sequence alignment and satisfaction of spatial restraints

Thermodynamic energy minimization and conformational sampling

Novelty of Output

Entirely novel folds and sequences not found in nature

Limited to known folds; models are variants of the template

Can theoretically predict novel folds, but historically limited to small proteins

Scalability

Scalable to large complexes and symmetric assemblies

Scalable to any target with an identifiable homolog

Computationally intractable for proteins >150 residues

Key Limitation

Design success requires experimental validation; function is not guaranteed

Cannot model targets without a known structural homolog

Inaccurate energy functions and the vast conformational search space

Representative Tools

ProteinMPNN, RFdiffusion, Rosetta FunFolDes

MODELLER, SWISS-MODEL

Rosetta AbInitio, QUARK

Prasad Kumkar

About the author

Prasad Kumkar

CEO & MD, Inference Systems

Prasad Kumkar is the CEO & MD of Inference Systems and writes about AI systems architecture, LLM infrastructure, model serving, evaluation, and production deployment. Over 5+ years, he has worked across computer vision models, L5 autonomous vehicle systems, and LLM research, with a focus on taking complex AI ideas into real-world engineering systems.

His work and writing cover AI systems, large language models, AI agents, multimodal systems, autonomous systems, inference optimization, RAG, evaluation, and production AI engineering.